News Focus
News Focus
Followers 30
Posts 5248
Boards Moderated 0
Alias Born 10/16/2012

Re: biopharm post# 315403

Wednesday, 10/25/2017 11:20:23 AM

Wednesday, October 25, 2017 11:20:23 AM

Post# of 347009
Yep, hopefully the IP can be sold for maximum value. I doubt Johnson/Swartz/Pohl can do it.

What is Steve King going to do when the R&D is sold off? Please don’t tell me he is part of the deal. If anything, adding Steve in with the sale of the IP would devalue it. Us shareholders want maximum value!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y